KINNATE BIOPHARMA INC (KNTE)
US49705R1059 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 0.00 | 25.70M | 33.60M | N/A | N/A | |||
| Cash Equivalents | 57.00M | 29.30M | 116.10M | 365.50M | 76.50M | |||
| Marketable Securities | 97.04M | 172.20M | 103.40M | 31.40M | N/A | |||
| Receivables | N/A | N/A | N/A | 0.00 | 1.00M | |||
| Other Current Assets | 4.14M | 3.60M | 5.60M | 3.30M | 0.00 | |||
| Total Current Assets | 158.18M | 230.80M | 258.70M | 400.20M | 77.50M | |||
| Non-Current Assets | ||||||||
| PPE Net | 4.76M | 6.40M | 1.00M | 400.00K | 200.00K | |||
| Investments And Advances | 10.26M | 39.10M | 105.40M | N/A | N/A | |||
| Other Non-Current Assets | 409.00K | 2.40M | 1.80M | N/A | N/A | |||
| Total Non-Current Assets | 15.43M | 48.00M | 108.20M | 400.00K | 100.00K | |||
| TOTAL ASSETS | 173.60M | 278.80M | 366.90M | 400.60M | 77.60M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 9.96M | 14.20M | 9.20M | 3.40M | 1.00M | |||
| Accounts Payable | 2.03M | 3.00M | 3.10M | 3.90M | 1.00M | |||
| Total Current Liabilities | 11.99M | 17.20M | 12.40M | 7.30M | 1.90M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 2.28M | 3.20M | N/A | N/A | N/A | |||
| Total Non-Current Liabilities | 2.28M | 38.20M | 35.00M | 0.00 | 0.00 | |||
| TOTAL LIABILITIES | 14.28M | 55.40M | 47.40M | 7.30M | 1.90M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -372.01M | -259.40M | -143.10M | -53.30M | -17.60M | |||
| Additional Paid In Capital | 531.35M | 484.20M | 463.10M | 446.60M | 100.00K | |||
| Minority Interest | 0.00 | 35.00M | 35.00M | N/A | N/A | |||
| Common Shares | 5.00K | 0.00 | 0.00 | 0.00 | 93.20M | |||
| Other Shareholders' Equity | -12.00K | -1.40M | -500.00K | 0.00 | N/A | |||
| Shares Outstanding | 47.12M | 44.30M | 43.90M | 43.50M | 43.30M | |||
| Tangible Book Value per Share | 3.38 | 5.05 | 7.28 | 9.04 | -0.40 | |||
| Total Shareholders' Equity | 159.33M | 223.50M | 319.50M | 393.30M | 75.70M | |||
| TOTAL LIABILITIES AND EQUITY | 173.60M | 278.80M | 366.90M | 400.60M | 77.60M | |||
| Statistics | ||||||||
| Current Ratio | 13.19 | 13.42 | 20.86 | 54.82 | 40.79 | |||
| Return On Assets (ROA) | -64.89% | -41.70% | -24.46% | -8.93% | -12.81% | |||
| Return On Equity (ROE) | -70.70% | -52.02% | -28.09% | -9.09% | -13.13% | |||
All data in USD , ROIC based on taxRate of 0.21